Skip to content
Wenlo
Sign in
← Markets

Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc. (BCLI) — Form 8-K: Current report

8-KBCLIFiled Nov 16, 2026, 11:16 AM ET· Period Nov 16, 2026

About this filing

Brainstorm Cell Therapeutics Inc. (BCLI) filed an 8-K on Nov 16, 2026 reporting results of operations (earnings) (Item 2.02), with exhibits (Item 9.01).

Key facts

  • Item 2.02 · Results of operations (earnings)
  • Item 9.01 · Financial statements and exhibits

More BCLI filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.